Search results
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Zacks via Yahoo News· 2 weeks agoTaking full advantage of the stock market and investing with confidence are common goals for new and...
Top Research Reports for Qualcomm, Alibaba & HSBC
Zacks via Yahoo News· 3 weeks agoToday's Research Daily features new research reports on 16 major stocks, including Qualcomm Inc. (QCOM), Alibaba Group Holding Ltd. (BABA) and HSBC...
Illumina (ILMN) Advances in NGS With DRAGEN v4.3 Launch
Zacks via Yahoo News· 3 weeks agoIllumina, Inc. ILMN has progressed in genomic research with the recent launch of DRAGEN v4.3. This...
ETFs in Focus on the Upcoming S&P 500 Shake-Up
Zacks via Yahoo News· 4 weeks agoThe popular S&P Dow Jones Indices are set to get the customary new look this month. Every year, on the third Friday of June, the S&P 500, S&P MidCap 400...
KKR & 2 More Stocks to Join S&P 500 Index Post Rebalancing
Zacks via Yahoo News· 4 weeks agoShares of KKR & Co. Inc. KKR, CrowdStrike Holdings, Inc. CRWD and GoDaddy Inc. GDDY gained 7.7%,...
David Cameron timeline: from MP to PM to Foreign Secretary
Evening Standard via Yahoo News· 1 month agoFormer prime minister and current foreign secretary David Cameron has asked Britons residing...
The Zacks Analyst Blog Highlights Union Pacific, Freeport-McMoRan, Block, Xcel and Illumina
Zacks via Yahoo News· 2 months agoFor Immediate Release Chicago, IL – May 15, 2024 – Zacks.com announces the list of stocks featured...
Illumina (ILMN) Q1 Earnings Beat, Adjusted Operating Loss Widens
Zacks via Yahoo News· 2 months agoIllumina Inc. ILMN reported first-quarter 2024 adjusted earnings per share (EPS) of 9 cents, which...
Will These 5 MedTech Stocks Beat Forecasts This Earnings Season?
Zacks via Yahoo News· 2 months agoHere is a sneak peek into how the five MedTech stocks, HOLX, ZBH, ILMN, TFX and BRKR, are expected...
Analysts Estimate AbCellera Biologics Inc. (ABCL) to Report a Decline in Earnings: What to Look Out...
Zacks via Yahoo News· 2 months agoAbCellera Biologics (ABCL) doesn't possess the right combination of the two key ingredients for a...